NEW YORK (GenomeWeb News) – Bruker Biosciences today reported that total revenues for the second quarter increased nearly 10 percent as net income jumped 69 percent.
 
The report caused shares in Bruker to trade up 6 percent, or $.35, at $5.86 in mid-afternoon trading.
 
Receipts for the three months ended June 30 increased to $78 million from $71 million year over year.
 
R&D costs declined 3 percent to $10.6 million from $11 million from the comparable quarter a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.